Related Experiment Video

Updated: May 20, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Peripartum cardiomyopathy

Uri Elkayam1, Sawan Jalnapurkar, Mohamad Barakat

  • 1Division of Cardiology, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA. elkayam@usc.edu

Cardiology Clinics
|July 21, 2012
PubMed

Insights

Peripartum cardiomyopathy (PPCM) is a rare form of heart failure. Recent European guidelines update the definition of PPCM, improving diagnosis and management for pregnant women.

Area of Science:

  • Cardiology
  • Maternal Health
  • Heart Failure

Background:

  • Peripartum cardiomyopathy (PPCM) was first defined in 1971 by Demakis et al. based on specific clinical criteria.
  • The original PPCM criteria are now recognized as arbitrary, and the condition can manifest earlier in pregnancy.
  • A European Society of Cardiology working group has recently updated the definition of PPCM.

Purpose of the Study:

  • To discuss the updated definition, causes, clinical presentation, prognosis, and treatment of peripartum cardiomyopathy (PPCM).
  • To provide a comprehensive overview of PPCM, including related aspects.

Main Methods:

  • Review and synthesis of existing literature and guidelines.
  • Discussion based on the European Society of Cardiology's updated PPCM working group criteria.
  • Exploration of etiological factors, clinical manifestations, and therapeutic strategies.

Main Results:

  • The definition of PPCM has been refined to better capture earlier presentations and arbitrary criteria.
  • The article covers the multifaceted aspects of PPCM, from etiology to management.

Conclusions:

  • Updated diagnostic criteria for PPCM are crucial for timely and accurate diagnosis.
  • Comprehensive understanding and management of PPCM are essential for improving maternal and cardiac outcomes.
  • Further research into PPCM etiology and treatment is warranted.

More Related Videos

Noninvasive Electrocardiography in the Perinatal Mouse04:36

Noninvasive Electrocardiography in the Perinatal Mouse

Published on: June 12, 2020

An Intact Pericardium Ischemic Rodent Model07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...